Combining a polygenic risk score (PRS) with traditional biomarkers can help clinicians better estimate a patient’s risk of developing coronary artery disease (CAD), according to new UK Biobank data.
As predictive medicine advances, legal scholars warn that decades-old federal guidelines could set up a potential clash between your genes and your job. By Emily Baumgaertner Nunn Imagine this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results